Expectations trend
FY2027 · fiscal year ending 2027-08-31 · fmp
Northern Technologies International Corp (NTIC)
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-11-04
$7.58-1.81%
Close 2026-11-05 · 1-day change
NASDAQMaterialsChemicals - SpecialtySnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for NTIC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Focus on reducing outstanding debt | A primary condition in Northern Technologies International Corp's published investment case. The stated target is Maintain suspension of dividends to prioritize debt reduction through FY26. | Intact | Company resumes dividends without significant debt reduction progress by FY26 end | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-08-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 17, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
NTIC is a small-cap growth business with a long-term thesis built on sales expansion and higher-margin products. The thesis is intact, and the signal has improved from cautious to mixed, but recent financial performance is neutral and risk is elevated.
The valuation evidence is mixed: NTIC is described as expensive overall, while one comparison shows it trading at a premium to peers and another describes it as cheap versus peers. The expectations gap is negative, but model confidence is low, so the evidence does not support a firm read on what the market assumes.
In the near term, sales growth may continue, but recent losses and a 477-basis-point gross-margin decline show that profitability remains challenged. Management expects pricing and procurement steps to help margins, while debt reduction and liquidity remain priorities; consecutive earnings misses make another miss a meaningful risk. Over the multi-year view, growth depends on expanding ZERUST oil and gas sales and Natur-Tec applications while improving profitability.
The next earnings update is a key near-term swing factor: a guidance cut would weaken the thesis, while progress on margins would support management’s stated plan. Over the next 1 to 3 years, the setup also depends on whether Materials-sector bellwethers continue to report strength or begin to signal a weaker backdrop.
The multi-year view remains intact, supported by sales growth priorities and a favorable sector backdrop, but margin pressure, recent losses, and elevated earnings risk leave execution uncertain. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Improve profitability and reduce net losses |
| Management targets improved profitability despite recent losses. |
| Under Pressure |
| Net income remains negative or worsens through FY27 |
Net income: $-263,291 FY2026-Q3; GAAP. Published target: Achieve positive net income by FY27. Annual target cannot be compared with a quarterly or TTM observation. Jul 9, 2026-263,291 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain sales growth | A primary condition in Northern Technologies International Corp's published investment case. The stated target is Achieve at least 10% revenue growth in FY27, reaching ~$100 million. | Improving | Revenue growth falls below 10% in FY27 | Revenue growth: 12.59% FY2026-Q3; GAAP. Published target: Achieve at least 10% revenue growth in FY27, reaching ~$100 million. Annual target cannot be compared with a quarterly or TTM observation. Jul 9, 202612.586145 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.30 → $0.30 · observed estimates
$0.10B → $0.10B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-25 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-26 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-27 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-28 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-29 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-30 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-07-31 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-01 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-02 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-03 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-04 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-05 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-06 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-07 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-08 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-09 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-10 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-12 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-13 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-14 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-15 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-16 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-17 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-18 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-19 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-20 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-21 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-22 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-23 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-24 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-25 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-26 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-27 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-28 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-29 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-30 | $0.30 | $101,600,000 | 1 / 1 |
| 2026-08-31 | $0.30 | $101,600,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.